辛伐他汀治疗冠心病合并高脂血症患者疗效分析  

The Analysis of Simvastatin Treatment of Coronary Artery Disease in Patients with Combined Hyperlipidemia

作　　者：曲辉[1] 刘计荣[1] 

机构地区：[1]华北电力大学校医院内科,北京102206

出　　处：《中国医药导刊》2012年第10期1761-1761,1763,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:研究临床中辛伐他汀治疗冠心病合并高脂血症的治疗效果。方法:将76例冠心病合并高脂血症患者随机分为观察组与对照组两组,每组38例,观察组患者给予辛伐他汀,对照组给予血脂康胶囊治疗。观察两组患者的总胆固醇、甘油三酯及高低密度脂蛋白等指标的变化情况。结果:治疗4周后与治疗前比较,组内患者的血脂水平有显著的统计学差异(P<0.05),而组间相比无显著的统计学差异(P>0.05);治疗8周后,两组之间比较有显著的统计学差异(P<0.05)。结论:辛伐他汀治疗冠心病合并高脂血症临床疗效满意。Objective：To study the effects in the clinical treatment of Coronary heart disease and hyperlipidemia with Simvastatin.Methods：76 cases of coronary heart disease with hyperlipidemia were randomly divided into two groups： Observation group and Comparison group,and each group with 38 cases.The observation group was treated with simvastatin and the control group was treated with Xuezhikang.The changes in indicators was Observed in patients with total cholesterol,Triglycerides,high and low density lipoprotein.Results：Compared treatment after 4 weeks with before treatment,the lipid levels of patients were with statistically significant difference（P0.05）.There was no statistically significant difference（P0.05） between differences in the two groups.There was statistically significant difference（P0.05） in the comparison of patients after 8 weeks’ treatment.Conclusion：The clinical effect on simvastatin treatment for coronary heart disease and hyperlipidemia is satisfied.

关 键 词：辛伐他汀 冠心病合并高脂血症 疗效观察 

分 类 号：R541.4[医药卫生—心血管疾病] R589.2[医药卫生—内科学]